AVEVA Group delivers strong results and makes continued progress against medium-term targets

DirectorsTalk Interviews FTSE 100

AVEVA Group (LON:AVV) has announced its results for the six months ended 30 September 2019. Summary results Six months ended 30 September H1 FY20 H1 FY19 Change Revenue1 £391.9m £336.5m 16.5% Recurring revenue2 £242.5m £170.7m 42.1% Adjusted EBIT3 £90.6m £54.4m 66.5% Adjusted EBIT margin 23.1% 16.2% +690bps Profit/(Loss) before tax £24.0m £(5.5)m – Adjusted3 diluted earnings per share 43.31p 26.25p 65.0% …

Vodafone executing on strategic priorities

DirectorsTalk Interviews FTSE 100

Vodafone (LON:VOD) has announced its results for the six months ended 30 September 2019. Financial highlights H1 organic service revenue up 0.3%* as Q2 returned to growth (Q1: -0.2%, Q2: +0.7%), supported by improvements in South Africa, Spain and Italy, with solid retail performance in Germany and strong commercial acceleration in the UK. Organic adjusted EBITDA up 1.4%*, reflecting €0.2 …

AstraZeneca presents results from the positive Phase III TULIP 2 trial for anifrolumab

DirectorsTalk Interviews FTSE 100

AstraZeneca (LON:AZN) has presented detailed results from the positive Phase III TULIP 2 trial for anifrolumab, a potential new medicine for the treatment of moderate to severe systemic lupus erythematosus (SLE), which demonstrated superiority across multiple efficacy endpoints versus placebo, with both arms receiving standard of care. On the primary endpoint, anifrolumab achieved a statistically significant and clinically meaningful reduction in …

DCC reports strong first half performance

DirectorsTalk Interviews FTSE 100

DCC (LON:DCC), the leading international sales, marketing and support services group, has announced its results for the six months ended 30 September 2019. Highlights 2019 2018 % change Revenue £7.312bn £7.418bn -1.4% Adjusted operating profit1,2 £162.6m £141.9m +14.5% DCC LPG £49.0m £40.9m +19.8% DCC Retail & Oil £59.7m £56.3m +6.0% DCC Technology £25.4m £17.8m +42.6% DCC Healthcare £28.5m £26.9m +5.8% …

Persimmon Plc and OnTheMarket sign listing agreement

DirectorsTalk Interviews FTSE 100

OnTheMarket plc (LON: OTMP), the agent-backed company which operates the OnTheMarket.com property portal, has announced that it has signed a listing agreement with Persimmon Plc (LON: PSN), one of the UK’s leading house builders. Under the agreement, which covers listing and additional advertising products, Persimmon Plc will list all its residential developments at OnTheMarket from both its Persimmon and Charles …

Rightmove PLC

Rightmove plc CFO Robyn Perriss steps down

DirectorsTalk Interviews FTSE 100

Rightmove plc (LON: RMV) announced that Robyn Perriss has informed the Board that she intends to step down as Finance Director of the Group. This will occur at a date to be agreed in due course, but is expected to be during Q2 2020. Robyn will continue to act as Finance Director for the Group over the coming months and …

AstraZeneca PLC Roxadustat pooled analyses: no increased CV risk

DirectorsTalk Interviews FTSE 100

AstraZeneca (LON: AZN) and FibroGen Inc. have presented pooled efficacy and cardiovascular safety analyses from the pivotal Phase III programme assessing roxadustat for the treatment of patients with anaemia from chronic kidney disease. The pooled CV safety analyses showed that roxadustat, an oral first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), did not increase the risk of MACE, MACE+ and all-cause …

Informa PLC

Informa PLC demonstrates resilience and performance

DirectorsTalk Interviews FTSE 100

Informa plc (LON: INF), the International Exhibitions, Events, Information Services and Advanced Learning Group, has issued a trading update for the 10-month period ending 31 October 2019. Key Highlights · Performance…Continued growth in revenue, adjusted profit, earnings and cashflow; full year performance on track; · Growth…Group underlying revenue growth of 2.8% for the ten months to 31 October 2019, ahead …

Polymetal International plc 18% increase in Ore Reserves at Kyzyl gold deposit

DirectorsTalk Interviews FTSE 100

Polymetal International (LON: POLY) has announced an 18% increase in Ore Reserves at Kyzyl gold deposit to 8.5 Moz of gold in accordance with the JORC Code (2012). “We have concluded the first stage of extending open-pit life-of-mine at our flagship operation. The next step is to estimate Ore Reserves at East Bakyrchik in Q4 2020”, said Vitaly Nesis, Group …

Astrazeneca plc

AstraZeneca presented results from Phase III OLYMPUS and ROCKIES trials

DirectorsTalk Interviews FTSE 100

AstraZeneca (LON:AZN) has presented detailed results from the Phase III OLYMPUS and ROCKIES trials showing that roxadustat significantly increased haemoglobin levels in non-dialysis-dependent and dialysis-dependent patients with anaemia from chronic kidney disease, respectively. The OLYMPUS trial compared roxadustat to placebo while the ROCKIES trial compared roxadustat to epoetin alfa. The results were presented today during two oral sessions at the …